By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 million on U.S. advertising ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...

Make it stop. Ozempic's maker has taken the warehouse of cash it has made to reunite the "I'm a Mac" actors for another ...

Novo Nordisk’s new Ozempic ads star Justin Long and John Hodgman, the “Mac” and “PC” of an iconic Apple campaign, to promote ...

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

Years after signing off as "a Mac" and "a PC," Justin Long and John Hodgman have reunited for another ad campaign that you ...

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

Ozempic’s website says its GLP-1 has more FDA-approved uses than other GLP-1s.

Popular weight-loss drugs are meant to be lifelong medications treating a disease, not lifestyle fixes.

Novo Nordisk (NVO) stock is in focus as the company's advertising expenditure for its GLP-1s, Wegovy and Ozempic, exceeds that for Lilly's (LLY) rivals. Read more here.